Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2 - Nuclear factor kappa B (NF kappa B)-inducing kinase requirement for activation of activating protein 1 and NF kappa B but not of c-Jun N-terminal kinase/stress-activated protein kinase

被引:105
作者
Natoli, G
Costanzo, A
Moretti, F
Fulco, M
Balsano, C
Levrero, M
机构
[1] UNIV ROMA LA SAPIENZA,FDN ANDREA CESALPINO,I-00161 ROME,ITALY
[2] UNIV PALERMO,IST MED INTERNA,I-90100 PALERMO,ITALY
[3] UNIV AQUILA,DIPARTIMENTO MED INTERNA,I-86100 LAQUILA,ITALY
关键词
D O I
10.1074/jbc.272.42.26079
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Like other members of the tumor necrosis factor (TNF) receptor family, p55 TNF receptor 1 (TNF-R1) lacks intrinsic signaling capacity and transduces signals by recruiting associating molecules, The TNF-R1 associated death domain protein interacts with the p55 TNF-R1 cytoplasmic domain and recruits the Fas-associated death domain protein (which directly activates the apoptotic proteases), the protein kinase receptor interacting protein, and TNF receptor-associated factor 2 (TRAF2), TRAF2 has previously been demonstrated to activate both transcription factor nuclear factor kappa B (NF kappa B) and the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) pathway, which in turn stimulates transcription factor activating protein 1 (AP1) mainly via phosphorylation of the c-Jun component. We have investigated the signaling properties of NF kappa B-inducing kinase (NIK), a TRAF2-associated protein kinase that mediates NF kappa B induction, NM was found to be unable to activate JNK/SAPK, mitogen-activated protein kinase, or p38 kinase, Moreover, NIK was not required for JNK/SAPK activation by TNF-R1, thus representing the first TNF-R1 complex component to dissect the NF kappa B and the JNK/SAPK pathways. Despite being unable to activate JNK/SAPK and mitogen-activated protein kinase, NIK strongly activated AP1 and was required for TNF-R1-induced AP1 activation, Therefore, NIK links TNF-R1 to a novel, JNK/SAPK-independent, AP1 activation pathway.
引用
收藏
页码:26079 / 26082
页数:4
相关论文
共 41 条
[1]   FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase [J].
AdamKlages, S ;
Adam, D ;
Wiegmann, K ;
Struve, S ;
Kolanus, W ;
SchneiderMergener, J ;
Kronke, M .
CELL, 1996, 86 (06) :937-947
[2]   PHORBOL ESTER INDUCIBLE GENES CONTAIN A COMMON CIS ELEMENT RECOGNIZED BY A TPA-MODULATED TRANS-ACTING FACTOR [J].
ANGEL, P ;
IMAGAWA, M ;
CHIU, R ;
STEIN, B ;
IMBRA, RJ ;
RAHMSDORF, HJ ;
JONAT, C ;
HERRLICH, P ;
KARIN, M .
CELL, 1987, 49 (06) :729-739
[3]  
Baker SJ, 1996, ONCOGENE, V12, P1
[4]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[5]   A NOVEL PROTEIN THAT INTERACTS WITH THE DEATH DOMAIN OF FAS/APO1 CONTAINS A SEQUENCE MOTIF RELATED TO THE DEATH DOMAIN [J].
BOLDIN, MP ;
VARFOLOMEEV, EE ;
PANCER, Z ;
METT, IL ;
CAMONIS, JH ;
WALLACH, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) :7795-7798
[6]   Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death [J].
Boldin, MP ;
Goncharov, TM ;
Goltsev, YV ;
Wallach, D .
CELL, 1996, 85 (06) :803-815
[7]   PROLONGED ACTIVATION OF JUN AND COLLAGENASE GENES BY TUMOR NECROSIS FACTOR-ALPHA [J].
BRENNER, DA ;
OHARA, M ;
ANGEL, P ;
CHOJKIER, M ;
KARIN, M .
NATURE, 1989, 337 (6208) :661-663
[8]   INDUCTION OF C-FOS EXPRESSION THROUGH JNK-MEDIATED TCF/ELK-1 PHOSPHORYLATION [J].
CAVIGELLI, M ;
DOLFI, F ;
CLARET, FX ;
KARIN, M .
EMBO JOURNAL, 1995, 14 (23) :5957-5964
[9]   FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS [J].
CHINNAIYAN, AM ;
OROURKE, K ;
TEWARI, M ;
DIXIT, VM .
CELL, 1995, 81 (04) :505-512
[10]   Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway [J].
Chirillo, P ;
Falco, M ;
Puri, PL ;
Artini, M ;
Balsano, C ;
Levrero, M ;
Natoli, G .
JOURNAL OF VIROLOGY, 1996, 70 (01) :641-646